Several studies have found that mutation in the genes associated with hepatic lipid metabolism, including PNPLA3, predispose to the development of NAFLD, hepatic fibrosis, and HCC in the presence of a metabolic disorder condition24,25. This evidence concerns the gene PNPLA3 and Hepatic fibrosis.